Navigation Links
A gene within a gene contributes to the aggressiveness of acute myeloid leukemia
Date:4/21/2014

COLUMBUS, Ohio A small gene that is embedded in a larger, well-known gene is the true leukemia-promoting force usually attributed to the larger gene, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James).

The findings are published in the journal Science Signaling.

The larger host gene is called BAALC (pronounced "Ball C"). The smaller embedded gene is called microRNA-3151 (miR-3151). The study investigated the degree to which each of the genes contributes to the development of acute myeloid leukemia (AML).

"We discovered that the smaller microRNA gene, and not the larger host gene, is the major oncogenic driver of the two molecules in AML," says principal investigator Albert de la Chapelle, MD, PhD, professor of Medicine and the Leonard J. Immke Jr. and Charlotte L. Immke Chair in Cancer Research.

"When both genes are highly expressed, it means a bad prognosis for patients, but our experiments indicate that it is high expression of miR-3151 that really matters. Overexpression of BAALC alone had only limited cancer-causing activity," he says.

The researchers discovered that miR-3151 promotes the development of leukemia by blocking a gene called TP53. Normally, TP53 is a central "tumor-suppressor" gene that protects against cancer by causing a cell with serious gene damage to self-destruct. "When miR-3151 blocks TP53 in the tumor cells, it enables the cells to survive, divide and grow faster," says co-senior author Clara D. Bloomfield, MD, Distinguished University Professor and Ohio State University Cancer Scholar.

"We also show that miR-3151 promotes growth in malignant melanoma cells in the same way, suggesting that the molecule might play a role in solid-tumor development," says Bloomfield, who is also senior adviser to the OSUCCC James and holds the William Greenville Pace III Endowed Chair in Cancer Research.

Last, the researchers show that miR-3151 overexpression may be inhibited by the drug bortezomib, a proteasome inhibitor, suggesting a possible therapy for miR-3151 overexpression.

MicroRNAs are a class of molecules that cells use to help regulate the kinds and amount of proteins they make. "About one-third of the several hundred known human microRNAs are encoded in host genes," says first author Ann-Kathrin Eisfeld, MD, a postdoctoral researcher who works in the laboratory of study co-authors de la Chapelle and Bloomfield.

Specifically, they are located in areas of genes called introns, short stretches of DNA that are not involved in making a protein. "We know very little about how microRNAs located within introns are regulated and how they interact with their host genes," Eisfeld says. "These findings provide an important example of that interaction."

The researchers found, for example, that miR-3151 has the capability to be active on its own, independent of the host gene.

For this study, de la Chapelle, Bloomfield, Eisfeld and their colleagues used human AML cells, cell lines and an animal model to investigate the overexpression of miR-3151 and BAALC in older patients with cytogenetically normal AML. Key technical findings include:

  • MiR-3151 directly targets PT53 and seven other genes in the TP53 pathway;
  • Overexpressing miR-3151 promotes AML-cell growth;
  • BAALC overexpression enhances that effect while blocking miR-3151 or overexpressing TP53 reverses it;
  • miR-3151 alone and in combination with BAALC promotes leukemia development in an animal model.


'/>"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Wexner Medical Center
Source:Eurekalert

Related medicine news :

1. For Healthier Eating, Keep Fruits, Veggies Within Reach
2. Ketamine improved bipolar depression within minutes
3. Family first - caring within UK Bangladeshi and Pakistani communities
4. Researchers find new target deep within cancer cells
5. Immune responses can be generated locally within human melanoma skin metastases
6. Strategy May Help ER Docs Spot Heart Attacks Within an Hour
7. Smoking After Stroke Triples Risk of Death Within Year: Study
8. ACNP: Novel NMDA receptor modulator significantly reduces depression scores within hours
9. RazorInsights Reports Inclusion in KLAS Data, Gaining Traction within Community Hospital Segment
10. Ovarian cancer stem cell study puts targeted therapies within reach
11. Hearing Aid Device Expert of Upstate Hearing Instruments Provides 7 Key Tips to Encourage Hearing Aid Adoption within the Elderly Populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: